Stay updated on Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe history page now shows a new release note entry 'Revision: v3.5.4' replacing the previous 'Revision: v3.5.3', indicating a software update to the ClinicalTrials.gov interface rather than a change to the study record.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page header/footer shows an update to the interface version from v3.5.2 to v3.5.3, indicating a software/display release rather than a change to the trial record itself.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision history updated to include v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed on the history page.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 has been removed from the page history.SummaryDifference0.1%

Stay in the know with updates to Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.